gadopiclenol: Clinical Trials

6 trials of gadopiclenol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Recruiting 1, Unknown 1

Follow gadopiclenol: new trials by email Literature Review of gadopiclenol trials Research Report on gadopiclenol

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease
gadopiclenol, Gadoterate meglumine (Dotarem) - Steno-occlusive Disease
Phase 3RecruitingGuerbet3152026-07-282026-10-07
Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics
Gadopiclenol, Gadobenate dimeglumine - Congenital Heart Disease
Phase 3UnknownUniversity of California, San Diego1602024-05-012024-05-09
Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas
Elucirem, Dotarem - Brain Tumor, Primary, Brain Tumor, Recurrent
Phase 3CompletedGuerbet1382023-09-072026-01-29
Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children
Gadopiclenol, Comparator (gadobutrol) - Lesion in Body Region, CNS Lesion
Phase 3CompletedGuerbet2402023-07-212026-06-25
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
gadopiclenol, Gadobutrol 1 MMOLE/ML Intravenous Solution - Lesion in Body Region
Phase 3CompletedGuerbet3242019-08-272025-10-27
Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
gadopiclenol, Gadobutrol 1Mmol/mL Solution for Injection Vial - CNS Lesion, Blood Brain Barrier Defect
Phase 3CompletedGuerbet2602019-06-032025-09-22

Conditions studied

Brain Neoplasms (1)  ·  Heart Defects, Congenital (1)

Sponsors

Guerbet (5)  ·  University of California, San Diego (1)

Countries

Hungary (4)  ·  Italy (4)  ·  Poland (4)  ·  United States (4)  ·  France (3)  ·  Germany (3)  ·  South Korea (3)  ·  Spain (3)  ·  Mexico (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Japan (1)  ·  Taiwan (1)

Top investigators

Albert Hsiao, MD/PhD (1)  ·  Frantz Hebert (1)  ·  Lorie Loevner, MD (1)  ·  Toshiaki Taoka, MD (1)

Results publications

PMID 36729404, PMID 37462494